Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun 19;114(4):30.
doi: 10.1007/s00395-019-0739-9.

Relaxin mitigates microvascular damage and inflammation following cardiac ischemia-reperfusion

Xiao-Ming Gao  1   2   3   4 , Yidan Su  5 , Shirley Moore  5 , Li-Ping Han  5 , Helen Kiriazis  5 , Qun Lu  5 , Wei-Bo Zhao  5 , Amanguli Ruze  6   7 , Bin-Bin Fang  6   7 , Ming-Jun Duan  6   7 , Xiao-Jun Du  8
Affiliations

Relaxin mitigates microvascular damage and inflammation following cardiac ischemia-reperfusion

Xiao-Ming Gao et al. Basic Res Cardiol. .

Abstract

Microvascular obstruction (MVO) and leakage (MVL) forms a pivotal part of microvascular damage following cardiac ischemia-reperfusion (IR). We tested the effect of relaxin therapy on MVO and MVL in mice following cardiac IR injury including severity of MVO and MVL, opening capillaries, infarct size, regional inflammation, cardiac function and remodelling, and permeability of cultured endothelial monolayer. Compared to vehicle group, relaxin treatment (50 μg/kg) reduced no-reflow area by 38% and the content of Evans blue as a permeability tracer by 56% in jeopardized myocardium (both P < 0.05), effects associated with increased opening capillaries. Relaxin also decreased leukocyte density, gene expression of cytokines, and mitigated IR-induced decrease in protein content of VE-cadherin and relaxin receptor. Infarct size was comparable between the two groups. At 2 weeks post-IR, relaxin treatment partially preserved cardiac contractile function and limited chamber dilatation versus untreated controls by echocardiography. Endothelial cell permeability assay demonstrated that relaxin attenuated leakage induced by hypoxia-reoxygenation, H2O2, or cytokines, action that was independent of nitric oxide but associated with the preservation of VE-cadherin. In conclusion, relaxin therapy attenuates IR-induced MVO and MVL and endothelial leakage. This protection was associated with reduced regional inflammatory responses and consequently led to alleviated adverse cardiac remodeling.

Keywords: Cardiac remodeling; Ischemia–reperfusion; Microvascular damage; Microvascular leakage; Microvascular obstruction; Relaxin.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

Publication types

MeSH terms

LinkOut - more resources